BUDA JUICE, INC. 8-K

What Happened Buda Juice, Inc. (BUDA) filed an 8‑K announcing the pricing and closing of its initial public offering. On January 7, 2026 the company sold 2,666,667 shares of common stock at $7.50 per share for gross proceeds of $20.0 million, and on January 8, 2026 it began trading on the NYSE American. The company entered into an underwriting agreement with Public Ventures, LLC (d/b/a MDB CAPITAL) as representative of the underwriters and issued underwriter warrants as partial compensation. The board also adopted the Buda Juice, Inc. 2025 Equity Incentive Plan.

Key Details

• Offering size: 2,666,667 shares at $7.50 per share for $20.0 million gross proceeds.
• Underwriter warrants: 266,667 warrants (10% of shares sold), exercisable 7/7/2026–1/7/2031 at $9.375 per share (125% of the offering price).
• Equity plan adopted: Buda Juice 2025 Equity Incentive Plan approved 1/7/2026 to permit equity- and cash-based awards to employees, directors, and consultants.
• Public listing: Press releases filed announcing pricing (1/7/2026) and commencement of trading on NYSE American (1/8/2026). Related agreements and plan filed as exhibits to the 8‑K.

Why It Matters The IPO provides Buda Juice with immediate public-market capital (gross $20M) that the company can use for growth and operating needs. The underwriter warrants create potential future dilution if exercised, but at an exercise price above the IPO price. The adopted equity incentive plan gives the company a mechanism to grant stock- and cash-based awards to attract and retain personnel now that it is public. The NYSE American listing establishes a public market and liquidity for shareholders.